Literature DB >> 9009125

Esophageal motor function in primary Sjögren's syndrome: correlation with dysphagia and xerostomia.

M Anselmino1, G Zaninotto, M Costantini, P Ostuni, A Ianniello, C Boccú, A Doria, S Todesco, E Ancona.   

Abstract

The incidence of dysphagia in patients with primary Sjogren's syndrome (pSS) has been underestimated and all too often ascribed to xerostomia, without considering the possible presence of esophageal motor abnormalities affecting other nonscleroderma connective tissue diseases. Esophageal and salivary functions were prospectively evaluated in 27 females who met the four criteria proposed by Fox for the diagnosis of pSS, using esophageal manometry after wet swallows and Saxon's test, respectively. Dysphagia was graded using a standard symptoms questionnaire and results were compared with those obtained in a group of 21 healthy controls. Seven patients with pSS (26%) had no swallowing discomfort, 2 (7.4%) had mild dysphagia, 7 (26%) had moderate dysphagia, and 11 (40.6%) had severe dysphagia. Saxon's test revealed an overall decrease in the salivary flow rate compared to controls, with no difference between patients with or without dysphagia. Esophageal manometry demonstrated the absence of any lower or upper esophageal sphincter function abnormalities in all patients. In the patients with pSS as a whole, manometric study of the esophageal body showed a motor pattern comparable with that of controls, with no difference between patients with and without dysphagia. Defective peristalsis, ie, the presence of simultaneous contractions in more than 30% of wet swallows was detected, however, in the distal tract of the esophagus of six patients (22.2%) and in the proximal tract of three (11.1%). All these patients had severe dysphagia and the modified Saxon's test revealed a salivary secretion comparable with that of patients with a normal peristalsis. Dysphagia is a very common complaint in patients with pSS and does not seem to correlate with xerostomia, which is a constant and typical finding of the disease. About one third of patients with pSS have an abnormal esophageal peristalsis that is responsible for severe dysphagia, whereas decreased salivary outflow exacerbates the swallowing discomfort. This has to be taken into account and justifies the routine use of esophageal manometry in patients with pSS. The cause of dysphagia in pSS patients without peristaltic disorders of the esophagus has to be investigated.

Entities:  

Mesh:

Year:  1997        PMID: 9009125     DOI: 10.1023/a:1018845323765

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Abnormal esophageal motility in primary Sjögren's syndrome.

Authors:  M Ramirez-Mata; F F Pena Ancira; D Alarcon-Segovia
Journal:  J Rheumatol       Date:  1976-03       Impact factor: 4.666

2.  Evaluation of unstimulated whole saliva flow rate and stimulated parotid flow as confirmatory tests for xerostomia.

Authors:  F N Skopouli; H I Siouna-Fatourou; C Ziciadis; H M Moutsopoulos
Journal:  Clin Exp Rheumatol       Date:  1989 Mar-Apr       Impact factor: 4.473

3.  Definition and criteria for Sjögren's syndrome used by the contributors to the First International Seminar on Sjögren's syndrome--1986.

Authors:  J U Prause; R Manthorpe; P Oxholm; M Schiødt
Journal:  Scand J Rheumatol Suppl       Date:  1986

4.  Abnormalities of gastric and esophageal emptying in polymyositis and dermatomyositis.

Authors:  M Horowitz; J D McNeil; G J Maddern; P J Collins; D J Shearman
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

5.  Excessive competence of the lower oesophageal sphincter after Nissen fundoplication: evaluation by three-dimensional computerised imaging.

Authors:  G Zaninotto; M Costantini; M Anselmino; C Boccù; F Bagolin; R Polo; E Ancona
Journal:  Eur J Surg       Date:  1995-04

6.  A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test.

Authors:  P F Kohler; M E Winter
Journal:  Arthritis Rheum       Date:  1985-10

7.  Objective measures of swallowing in patients with primary Sjogren's syndrome.

Authors:  A J Caruso; B C Sonies; J C Atkinson; P C Fox
Journal:  Dysphagia       Date:  1989       Impact factor: 3.438

8.  Esophageal motor function in primary Sjögren's syndrome.

Authors:  L Grande; G Lacima; E Ros; J Font; C Pera
Journal:  Am J Gastroenterol       Date:  1993-03       Impact factor: 10.864

9.  Oesophageal dysfunction in patients with primary Sjögren's syndrome.

Authors:  E B Tsianos; C D Chiras; A A Drosos; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

10.  Otolaryngological aspects of Sjögren's syndrome.

Authors:  J A Doig; K Whaley; W C Dick; G Nuki; J Williamson; W W Buchanan
Journal:  Br Med J       Date:  1971-11-20
View more
  12 in total

Review 1.  The laryngeal and esophageal manifestations of Sjögren's syndrome.

Authors:  Peter C Belafsky; Gregory N Postma
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

2.  Effects of reduced saliva production on swallowing in patients with Sjogren's syndrome.

Authors:  Nicole M Rogus-Pulia; Jeri A Logemann
Journal:  Dysphagia       Date:  2010-10-28       Impact factor: 3.438

3.  Oropharyngolaryngeal disorders in scleroderma: development and validation of the SLS scale.

Authors:  Chiara Vitali; Elisa Borghi; Arianna Napoletano; Francesca Polini; Monica Caronni; Paola Ammenti; Davide Cattaneo
Journal:  Dysphagia       Date:  2009-08-26       Impact factor: 3.438

4.  Changes in swallowing physiology and patient perception of swallowing function following chemoradiation for head and neck cancer.

Authors:  Nicole M Rogus-Pulia; Margaret C Pierce; Bharat B Mittal; Steven G Zecker; Jeri A Logemann
Journal:  Dysphagia       Date:  2014-01-09       Impact factor: 3.438

Review 5.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

6.  Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic).

Authors:  Virginia Fernandes Moça Trevisani; Aysa César Pinheiro; Sonia Cristina de Magalhães Souza Fialho; Marilena Leal Mesquita Silvestre Fernandes; Alisson Pugliesi; Sandra Gofinet Pasoto; Maria Lucia Lemos Lopes; Lissiane Karine Noronha Guedes; Samira Tatiyama Miyamoto; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lúcia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Nayara Libório-Kimura; Maria Carmen Lopes Ferreira Silva Santos; Diego Ustárroz Cantali; Juliana D 'Agostino Gennari; Karina Gatz Capobianco; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; Aline Pereira da Rocha; César Ramos Rocha-Filho; Fabiola Reis Oliveira; Valeria Valim
Journal:  Adv Rheumatol       Date:  2022-10-10

Review 7.  Esophageal Motility Disorders: Current Approach to Diagnostics and Therapeutics.

Authors:  Dhyanesh A Patel; Rena Yadlapati; Michael F Vaezi
Journal:  Gastroenterology       Date:  2022-02-25       Impact factor: 33.883

8.  Esophageal function and Sjögren's syndrome.

Authors:  Françoise Volter; Olivier Fain; Emmanuel Mathieu; Michel Thomas
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

9.  Manometric assessment of esophageal motility in patients with primary Sjögren's syndrome.

Authors:  Tufan Türk; Timur Pirildar; Ercan Tunç; Serhat Bor; Eker Doğanavşargil
Journal:  Rheumatol Int       Date:  2004-01-14       Impact factor: 2.631

10.  Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study.

Authors:  Kathleen Morrisroe; Molla Huq; Wendy Stevens; Candice Rabusa; Susanna M Proudman; Mandana Nikpour
Journal:  BMC Pulm Med       Date:  2016-09-27       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.